Cynapsus Therapeutics Reports 2014 Annual Results Mar 17, 2015 05:56PM
Two Global Directors Of Novartis And Alcon File Individual And Collective Gender Discrimination Case Mar 17, 2015 09:00AM
ThromboGenics' JETREA(r) Gains Approval in Brazil Mar 16, 2015 02:05AM
ThromboGenics Full Year 2014 Business Update Mar 12, 2015 12:49PM
Galderma Poised for Growth in the U.S. with Holistic Approach to Skin Health Mar 12, 2015 08:30AM


Mar 5, 2015 09:41AM ThromboGenics Appoints Dr Joseph Markoff as Scientific Advisor
Mar 2, 2015 11:55AM ThromboGenics Receives Positive CHMP Opinion for Ready Diluted Formulation of JETREA(r)
Feb 27, 2015 11:34AM Alcon (NVS) Reports RTH258 Phase 2 Met Primary Endpoint
Feb 5, 2015 02:06AM Thrombogenics Awarded EU1.1 million IWT Research Grant
Jan 22, 2015 04:02AM ThromboGenics Appoints Emmanuele Attout as Independent Non-Executive Director
Jan 15, 2015 05:30PM Akorn Confirms Generic Durezol(R) Patent Challenge
Jan 15, 2015 05:30PM Akorn Confirms Generic Durezol(R) Patent Challenge
Jan 7, 2015 01:00PM Whitlock Celebrates Continued Growth with a New State-of-the-Art Facility in Dallas
Jan 7, 2015 08:08AM ThromboGenics Appoints Dominique Vanfleteren as new Chief Financial Officer
Apr 9, 2014 06:34AM Novartis AG (NVS) Novartis Names New Division Leaders for Sandoz, Alcon
Dec 18, 2013 02:12PM Perrigo (PRGO) Names CEO Papa as Chairman; Announces Director Slate
Nov 22, 2013 07:05AM Novartis (NVS) Announces $5B Buyback Plan; Updates on Long-Term Expectations
Jan 18, 2013 07:43AM Novartis' (NVS) Alcon Receives Positive CHMP Opinion for Jetrea as VMT Treatment
Mar 16, 2012 07:04AM Novartis' (NVS) Unit Gets Exclusive Rights to Ocriplasmin Outside the U.S.
Oct 25, 2011 08:20AM Novartis (NVS) Misses Q3 EPS by 6c, Sales Miss Expectations, Offers Q4 Outlook
Sep 13, 2011 06:44AM Novartis (NVS) Updates on Long-Term Strategy; Comments on Plans for Alcon